跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 12,890 条关于
“X-linked Protoporphyria”
全部
12,890
临床试验
8,574
药物
791
机构
86
资讯
3,439
去年
Disc Medicine Gains FDA Alignment on Bitopertin Trial Design for Erythropoietic Protoporphyria
去年
Disc Medicine Advances Hematology Pipeline with Bitopertin NDA Plans and Phase 2 Trials
去年
Disc Medicine Announces End-of-Phase 2 Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria
11个月前
GondolaBio's PORT-77 Receives FDA Orphan Drug and Fast Track Designations for Rare Protoporphyria Treatment
去年
FDA Aligns with Gemini Therapeutics on APOLLO Trial Design for Bitopertin in Rare Porphyria Disorders
上个月
LEO Pharma Acquires Worldwide Rights to Dersimelagon for Up to $435 Million
昨天
FDA Accepts Dersimelagon NDA With Priority Review as LEO Pharma Closes Tanabe Acquisition
去年
Disc Medicine's Bitopertin Poised for Potential Accelerated FDA Approval in Erythropoietic Protoporphyria
2年前
FDA Grants Orphan Drug and Rare Pediatric Disease Designations to ATSN-201 for X-Linked Retinoschisis
10个月前
SonoThera Demonstrates Novel Ultrasound Gene Delivery for X-Linked Alport Syndrome Treatment
第 1 页,共 344 页
上一页
下一页